Christopher Kirk
2020
In 2020, Christopher Kirk earned a total compensation of $880.1K as President and Chief Scientific Officer at Kezar Life Sciences, a 55% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $152,167 |
|---|---|
| Option Awards | $289,938 |
| Salary | $426,000 |
| Other | $11,994 |
| Total | $880,099 |
Kirk received $426K in salary, accounting for 48% of the total pay in 2020.
Kirk also received $152.2K in non-equity incentive plan, $289.9K in option awards and $12K in other compensation.
Rankings
In 2020, Christopher Kirk's compensation ranked 9,132nd out of 13,090 executives tracked by ExecPay. In other words, Kirk earned more than 30.2% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 9,132 out of 13,090 | 30th |
Division Manufacturing | 3,907 out of 5,621 | 31st |
Major group Chemicals And Allied Products | 1,584 out of 2,254 | 30th |
Industry group Drugs | 1,385 out of 1,954 | 29th |
Industry Pharmaceutical Preparations | 1,020 out of 1,459 | 30th |
Source: SEC filing on April 26, 2022.
Kirk's colleagues
We found two more compensation records of executives who worked with Christopher Kirk at Kezar Life Sciences in 2020.